Stock screener

PCVX

Conviction 61HealthcareScan · Mon, Jul 20, 2026
Bearish engulfing
PCVX$55.51-1.23%
ResistanceSupportVol 14Insider sellCongress buyCongress sell
63 bars
Gilbert Cisneros
Gilbert Cisneros
4
2
Vol MA14 1.4M
Apr 20May 6May 26Jun 11Jul 1Jul 20
Vaxcyte, Inc.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.vaxcyte.com
Price55.51
Change-1.23%
Gap+0.80%
Rel volume1.81×
Avg volume1.89M
Avg $ vol106.72M
SMA 2056.53
SMA 5052.39
SMA 20051.44
Price vs 50+5.95%
Price vs 200+7.91%
MA stackbullish
50/200 cross
Supertrendup · 51.64
RSI (14)51
MACD hist-0.39
MACD crossbear · 3d
Stoch %K / %D13 / 22
ADX (14)27
+DI / −DI20 / 15
RSI divergence
MACD divergence
ATR %+4.29%
ADR %4.35%
52w high63.04
52w low29.67
From 52w high-11.94%
Above 52w low+87.09%
New 52w highNo
SqueezeOff
Bollinger width15.89%
%B0.39
Donchian pos42.83%
Donchian high61.77
Donchian low50.82
AVWAP (52w high)55.07
vs AVWAP high+0.80%
AVWAP (52w low)47.65
vs AVWAP low+16.49%
OBV trendUp
Chaikin MF (20)0.23
Today vs 20d1.81×
Avg vol (14d)1.4M
Avg vol (20d)1.89M
Avg $ vol (20d)106.72M
Market cap8.02B
RS 3m (vs SPY)-15.58%
RS 6m (vs SPY)+8.19%
RS line new highNo
Trend template6/8
Technical rank75.7
1 week-2.67%
1 month+9.55%
3 months-10.97%
6 months+15.55%
1 year+48.54%
YTD+19.48%
P/E-10.46
P/B2.68
P/S
P/FCF-11.98
EPS-5.63
Div yield
ROE-25.59%
ROA-22.90%
Debt/Eq
Current7.49
EV/EBITDA-8.55
Gross margin
Net margin
Rev growth
EPS growth-65.25%
Price target116.00
Target upside108.97%
Analyst ratingBuy
Institutional121.23%
Ent. value7.75B
Revenue
Net income-320.62M
Gross profit
Free cash flow-669.29M
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNasdaq
Shares out144.4M
Employees507
ListedFri, Jun 12, 2020
Free float126.82M
Float %87.8%
Short interest17.47M
Days to cover6.9d
Short volume76.1%
Squeeze score85 / 100
Next earnings
EPS forecast
Last EPS vs est−$2.30 vs −$1.86
Last surprise-23.7% miss
Setup gradeB
Conviction61 / 100
Pattern quality
Tech rank75.7 / 100
Group rank23 / 100
Status lane
Setup direction
Pattern family
Resistance
Support
Days since event
Candle confirmBearish engulfing
News sentiment

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in PCVX · 6 recent

All disclosures →
MemberSideAmount
Gilbert Cisneros
Gilbert Cisneros
house · CA · traded 2026-05-13
Buy$1K–$15K
Gilbert Cisneros
Gilbert Cisneros
house · CA · traded 2026-05-12
Buy$1K–$15K
Gilbert Cisneros
Gilbert Cisneros
house · D · CA · traded 2025-04-14
Buy$1K–$15K
Gilbert Cisneros
Gilbert Cisneros
house · D · CA · traded 2025-04-15
Buy$1K–$15K
Gilbert Cisneros
Gilbert Cisneros
house · D · CA · traded 2025-04-28
Buy$1K–$15K
Jefferson Shreve
Jefferson Shreve
house · R · IN · traded 2025-03-05
Sell$15K–$50K

Insider activity

SEC Form 4 transactions in PCVX · 4 buys · 6 sells

InsiderSideShares
Markels John
Director · Stock Option (right to buy) · 2026-07-16
Grant23.03K
PICKERING GRANT
CHIEF EXECUTIVE OFFICER · Common Stock · 2026-06-18
Sell1K
PICKERING GRANT
CHIEF EXECUTIVE OFFICER · Stock Option (right to buy) · 2026-06-18
Exercise225
PICKERING GRANT
CHIEF EXECUTIVE OFFICER · Common Stock · 2026-06-18
Exercise225
PICKERING GRANT
CHIEF EXECUTIVE OFFICER · Common Stock · 2026-06-18
Sell225
PICKERING GRANT
CHIEF EXECUTIVE OFFICER · Common Stock · 2026-06-18
Sell22.24K
GUGGENHIME ANDREW
PRESIDENT AND CFO · Common Stock · 2026-06-18
Exercise10K
GUGGENHIME ANDREW
PRESIDENT AND CFO · Common Stock · 2026-06-18
Sell10K
GUGGENHIME ANDREW
PRESIDENT AND CFO · Stock Option (right to buy) · 2026-06-18
Exercise10K
BRANDICOURT OLIVIER
Director · Common Stock · 2026-06-15
Grant2.19K

SEC filings

EDGAR filings in PCVX · 9 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.